This is a preview of subscription content, log in via an institution to check access.
Reference
Isacoff WH, et al. Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab-Paclitaxel, Oxaliplatin, and Bevacizumab for Patients with Advanced Pancreatic Cancer: A Retrospective Analysis. Targeted Oncology 13: 461-468, No. 4, Aug 2018. Available from: URL: http://doi.org/10.1007/s11523-018-0572-3 - USA
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1721, 32 (2018). https://doi.org/10.1007/s40278-018-52069-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-52069-0